CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-02 | Lichtenstein Chen Director | Option exercise · Restricted Share Units | −4,804 | 0 | ||
| 2025-11-26 | MIGNONE ROBERTO Director | Sale | −50,000 | $26.03 | $1.3M | 445,000 |
| 2025-11-20 | Fox Christine EVP, Head of U.S. Commercial | Option exercise 10b5-1 | +63,492 | 91,876 | ||
| 2025-11-20 | Fox Christine EVP, Head of U.S. Commercial | Sale 10b5-1 | −28,229 | $24.78 | $700K | 63,647 |
| 2025-11-20 | Fox Christine EVP, Head of U.S. Commercial | Option exercise · Restricted Share Units 10b5-1 | −63,492 | 126,984 | ||
| 2025-11-14 | Fox Christine EVP, Head of U.S. Commercial | Sale | −30,000 | $25.11 | $753K | 28,384 |
| 2025-11-06 | MIGNONE ROBERTO Director | Sale | −200,000 | $24.11 | $4.8M | 495,000 |
| 2025-11-06 | Weiss Amir Chief Accounting Officer | Sale | −12,300 | $24.44 | $301K | 17,950 |
| 2025-09-05 | McAvoy David R. EVP, Chief Legal Officer | Purchase | +1,113 | $18.86 | $21K | 13,027 |
| 2025-08-01 | Jover Placid See "Remarks" | Option exercise | +12,827 | 12,827 | ||
| 2025-08-01 | Jover Placid See "Remarks" | Sale | −6,053 | $15.16 | $92K | 6,774 |
| 2025-08-01 | Jover Placid See "Remarks" | Option exercise · Restricted Share Units | −12,827 | 38,484 | ||
| 2025-08-01 | Hughes Eric A See "Remarks" | Option exercise 10b5-1 | +52,742 | 52,742 | ||
| 2025-08-01 | Hughes Eric A See "Remarks" | Sale 10b5-1 | −52,742 | $15.16 | $799K | 0 |
| 2025-08-01 | Hughes Eric A See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −52,742 | 52,744 | ||
| 2025-06-12 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Sale 10b5-1 | −55,775 | $17.08 | $952K | 403,288 |
| 2025-06-06 | Vergis Janet S. Director | Option exercise | +9,632 | 73,697 | ||
| 2025-06-06 | Vergis Janet S. Director | Option exercise · Restricted Share Units | −9,632 | 0 | ||
| 2025-06-06 | Zaks Tal Zvi Director | Option exercise | +9,632 | 58,772 | ||
| 2025-06-06 | Zaks Tal Zvi Director | Option exercise · Restricted Share Units | −9,632 | 0 |
Page 12 of 76 · 1,517 trades